Cargando…
Ruthenium(II)/(III) DMSO-Based Complexes of 2-Aminophenyl Benzimidazole with In Vitro and In Vivo Anticancer Activity
New anticancer ruthenium(II/III) complexes [RuCl(2)(DMSO)(2)(Hapbim)] (1) and [RuCl(3)(DMSO) (Hapbim)] (2) (Hapbim = 2-aminophenyl benzimidazole) have been synthesized and characterized, and their chemotherapeutic potential evaluated. The interaction of the compounds with DNA was studied by both UV-...
Autores principales: | Elsayed, Shadia A., Harrypersad, Shane, Sahyon, Heba A., El-Magd, Mohammed Abu, Walsby, Charles J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570852/ https://www.ncbi.nlm.nih.gov/pubmed/32962014 http://dx.doi.org/10.3390/molecules25184284 |
Ejemplares similares
-
DMSO reduces the cytotoxicity of anticancer ruthenium complex KP1019 in yeast
por: Davis, Jonathan, et al.
Publicado: (2021) -
Hydrogenation of CO(2) to Formic Acid with a Highly Active Ruthenium Acriphos Complex in DMSO and DMSO/Water
por: Rohmann, Kai, et al.
Publicado: (2016) -
Assessing the role of membrane lipids in the action of ruthenium(III) anticancer compounds
por: Starosta, Radoslaw, et al.
Publicado: (2023) -
Ruthenium(II) and Iridium(III) Complexes as Tested Materials for New Anticancer Agents
por: Masternak, Joanna, et al.
Publicado: (2020) -
Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity
por: Riccardi, Claudia, et al.
Publicado: (2019)